#CrowdBeatsCorona
Aescuvest Leads Alliance of Crowdfunding Platforms in Fight Against COVID-19!
Discover your opportunities
Investment opportunities
Open for Investment
Lipozyt Marker
Diagnostic Tests for the Personalized Treatment of Type 2 Diabetes
Category
BioTech
Type
Loan
Investment
€103,100
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreeOpen for Investment
PharmGenomics
Coronascreen: Contactless, online-based Laboratory Diagnostics
Category
Digital Health
Type
Loan
Investment
€60,700
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
ImmunoLogik
ImmunoLogik’s candidate against coronavirus
Category
BioTech
Type
Loan
Investment
€0
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
Proteona Antibody Protection
SARS-CoV-2 Broadly Neutralizing Antibody Therapy
Category
BioTech
Type
Loan
Investment
€0
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
Emperra
Helping to make life with Diabetes mellitus easier
Category
Digital Health
Equity
TBA
Investment
€0
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
Alma Bio Therapeutics
Employs the Language of the Immune System to Improve Patients’ Health
Category
BioTech
Equity
TBA
Investment
€0
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
Mowoot
Solving intestinal transit disorders purely physical, non-drug, non-invasive.
Category
MedTech
Equity
TBA
Investment
€0
This investment opportunity is brokered by aescuvest GmbH on our independent platform aescuvest.de
Legal notice according to the German Capital Investments Act (VermAnlG): This investment carries considerable risks and may lead to an entire loss of the assets invested. The expected yield is not guaranteed and may be lower.
I agreePrivate Placement
NanoVelos
Getting drugs to their targets with significant side effects reduction
Category
BioTech
Equity
TBA
Investment
€0
New from the blog
-
Read full story
04.06.2020
How Surge-On Medical Defines the Future of Surgery
Defining the future of robotic surgery training and MIS instruments: Surge-on Medical started shaping their own VR trainer to deliver more value to the users.
-
Read full story
29.05.2020
Overview of Surge-on Medical’s campaign
The last nine months have been a thrill for Surge-on Medical. Since the launch of our equity crowdfunding campaign in August 2019, the company has been focused on raising funds and getting in touch with investors across Europe, without losing sight of daily operations and preparations for the future.
-
Read full story
20.05.2020
EIT Health Start-Up Rescue Instrument
Start-ups can now apply to receive up to €500,000 in co-investment from EIT Health in return for options. Through the new Start-up Rescue Instrument, EIT Health aims to alleviate the economic shock posed by the COVID-19 pandemic.
-
Read full story
13.05.2020
#CrowdBeatsCorona
Aescuvest Leads Alliance of Crowdfunding Platforms in Fight Against COVID-19
-
Read full story
13.05.2020
Steerable Punch Now with CE Mark
Surge-on Medical has achieved a great milestone this week: The Steerable Punch for knee arthroscopy has been registered and is recognized with the CE mark for Class I medical devices
-
Read full story
23.04.2020
Moving Forward Despite the Global Challenges
It was a successful 2019 for Surge-on Medical, as we overcame the equity crowdfunding barrier at Aescuvest.eu, a great way to end the preceding year.
-
Read full story
09.04.2020
In COVID-19-Times, Crowdfunding Could Serve as a Lifeline
Start-up CEOs will tell you that, even at the best of times, funds are difficult to raise. The slowdown (ok, crash landing) of economic activity the COVID-19 pandemic has caused, has all but dried up access to finance through conventional channels (e.g. venture capital).
-
Read full story
22.03.2020
#TakeBackControl
The coronavirus is spreading rapidly all over the world. Now is the time to get a grip on the global threat. In order to flatten the curve, fast reaction is essential.
-
Read full story
10.03.2020
COVID 19 Makes Markets Stumble
It is still not clear how dangerous the coronavirus really is for those it infects. But one thing is already sure: the impending epidemic is shaking up the economy and financial markets.
-
Read full story
05.03.2020
Is AI a Threat or an Opportunity for Healthcare?
Healthcare is one of the major success stories of our time, but it is also in crisis. Healthcare providers face rising demand, increasing delivery costs and workforce shortages, as well as the need to adapt to new ways of working that maximize the use of innovative technology to deliver better quality care.